Overview
The goal of this observational study is to investigate the potential differences in thrombogenicity between black and white patients admitted with atherothrombotic events including acute coronary syndrome, multi-vessel coronary disease, and ischemic stroke.
Participants will engage in laboratory testing and health outcome assessments.
Eligibility
Inclusion Criteria:
- Patients ≥18 years of age admitted with ACS, AIS, or multi-vessel CAD
- Competent mental condition to provide informed consent and able to participate in follow-ups
Exclusion Criteria:
- Pregnant women
- Currently enrolled in an investigational drug or device trial
- Undergoing treatment for neoplastic, autoimmune, or connective tissue disease
- COVID-19 infection within 30 days of enrollment
- Known history of hepatitis or HIV
- Deemed unfit to participate according to the investigator
- Known history of drug abuse
- Known platelet count of <100,000/mm3
- Hematocrit < 25%